Kymera Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Hi, good morning, everyone. Thanks for joining us on the final day of the Barclays Global Healthcare conference here in Miami. I'm Ellie Merle, very excited to have Chimera Therapeutics here with us today. They have one of, I think, the most exciting platform technologies in biotech.
Joining us from Kymera is Bruce Jacobs, Chief Financial Officer for Fireside Chat. Bruce, thank you so much for making the time. Maybe just high level to start, can you give us an overview of Chimera as a company and your growing pipeline and INI?
Sure, Ellie, so first of all, thanks for having us. I think this is the OG Miami March conference, so we're happy to be ending our week here. So thank you. Yeah, so, it's a good time to ask that question. Chimera is, actually coming up next month on our 10 year anniversary, of the company's founding. From the beginning, the company was founded to really capitalize on this exciting new modality, targeted protein degradation, and we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
